Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
+1,25%
1 110,47
+13,75
+1,25%
—1 096,721 098,741 113,821 098,74——
SIXC
Communications
SIXC
Communications
SIXC
-1,19%
604,07
-7,25
-1,19%
—611,32611,32611,32603,33——
SIXE
Energy
SIXE
Energy
SIXE
+2,56%
1 201,49
+29,95
+2,56%
—1 171,541 176,151 202,381 176,15——
SIXI
Industrials
SIXI
Industrials
SIXI
+1,01%
1 765,30
+17,67
+1,01%
—1 747,631 747,671 770,511 744,43——
SIXM
Financials
SIXM
Financials
SIXM
-0,17%
630,42
-1,07
-0,17%
—631,49631,23633,90627,95——
SIXR
Staples
SIXR
Staples
SIXR
-1,00%
841,45
-8,49
-1,00%
—849,94850,23850,23836,20——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
+0,35%
218,83
+0,77
+0,35%
—218,06218,06219,96218,02——
SIXT
Technology
SIXT
Technology
SIXT
+1,31%
3 582,23
+46,20
+1,31%
—3 536,033 549,423 590,523 543,38——
SIXU
Utilities
SIXU
Utilities
SIXU
+0,97%
913,89
+8,82
+0,97%
—905,07908,07916,83907,68——
SIXV
Health care
SIXV
Health care
SIXV
-0,38%
1 444,33
-5,53
-0,38%
—1 449,861 451,341 464,451 440,75——
SIXY
Discretionary
SIXY
Discretionary
SIXY
-0,72%
2 412,96
-17,51
-0,72%
—2 430,472 415,842 422,952 396,14——
UTHR:NASDAQ
United Therapeutics Corp
569,88 $
+0,87%
(+4,94) 1D
569,88 $
0,00% (0,00)
After hours
Closed: 11 մյս, 16:00:00 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for UTHR...
Open
566,96 $
High
580,45 $
Low
566,96 $
Mkt. cap
24,19 մլրդ
Avg. vol.
555,58 հզր
Volume
0,00
P/E ratio
21,03
52-wk high
609,35 $
52-wk low
272,12 $
EPS
27,09 $
Beta
0,60
Shares outstanding
42,45 մլն
No. of employees
1 հզր
News stories
From sources across the web
Profile
United Therapeutics Corporation is an American biotechnology company that develops pharmaceuticals and technologies related to organ transplantation, including xenotransplantation. Many of the company's products are focused towards lung disease and organ manufacturing. United Therapeutics is co-headquartered in Silver Spring, Maryland and Research Triangle Park, North Carolina, with additional facilities in Magog and Bromont, Quebec; Melbourne and Jacksonville, Florida; Blacksburg, Virginia; and Manchester, New Hampshire. Wikipedia
About United Therapeutics Corp
CEO-
Employees1,4 հզր
Founded1996
HeadquartersՍիլվեր Սփրինգ, Մերիլենդ, Միացյալ Նահանգներ
Sector-
Websiteunither.com
Last report
06 մյս, 2026 թ.
Fiscal Period
Q1 2026
EPS / Est. (USD)
5,82 $ / 7,04 $
-17,38%miss
Revenue / Est. (USD)
781,50 մլն / 797,38 մլն
-1,99%miss
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
2025 թ. հնս
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
Revenue
798,60 մլն
799,50 մլն
790,20 մլն
781,50 մլն
Cost of goods sold
87,60 մլն
100,90 մլն
103,40 մլն
133,40 մլն
Cost of revenue
87,60 մլն
100,90 մլն
103,40 մլն
133,40 մլն
Research and development expenses
134,00 մլն
127,50 մլն
139,50 մլն
138,20 մլն
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
190,80 մլն
181,80 մլն
189,90 մլն
184,10 մլն
Operating expense
324,80 մլն
309,30 մլն
329,40 մլն
322,30 մլն
Total operating expenses
412,40 մլն
410,20 մլն
432,80 մլն
455,70 մլն
Operating income
386,20 մլն
389,30 մլն
357,40 մլն
325,80 մլն
Other non operating income
3,90 մլն
300,00 հզր
800,00 հզր
15,30 մլն
EBT including unusual items
408,40 մլն
438,00 մլն
444,00 մլն
318,30 մլն
EBT excluding unusual items
434,10 մլն
433,00 մլն
398,30 մլն
379,90 մլն
Income tax expense
98,90 մլն
99,30 մլն
79,70 մլն
43,40 մլն
Effective tax rate
24,22%
22,67%
17,95%
13,63%
Other operating expenses
-
-
-
-
Net income
309,50 մլն
338,70 մլն
364,30 մլն
274,90 մլն
Net profit margin
38,76%
42,36%
46,10%
35,18%
Earnings per share
6,41
7,16
7,70
5,82
Interest and investment income
51,30 մլն
46,40 մլն
43,20 մլն
41,80 մլն
Interest expense
-7,30 մլն
-3,00 մլն
-3,10 մլն
-3,00 մլն
Net interest expenses
44,00 մլն
43,40 մլն
40,10 մլն
38,80 մլն
Depreciation and amortization charges
-
-
-
-
EBITDA
407,30 մլն
411,20 մլն
380,20 մլն
348,40 մլն
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer